Earnings Scheduled For March 9, 2023
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
Canonic Launches Six Second-Generation Cannabis Products With Higher THC And Rich Terpene Profiles
Canonic Ltd., a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) launched six second-generation hybrid cannabis products in Israel.
Evogene Q3 Revenue Grows 208% YoY, Here Are The Details
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized per the collaboration agreement of Evogene's subsidiary AgPlen
Evogene Q3 EPS $(0.16) Beats $(0.20) Estimate, Sales $466.00K Beat $100.00K Estimate. Cash, Cash Equivalents And Marketable Securities Of $$38M
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 15.79 percent increase over losses of $(0.19) per share from the same
Earnings Scheduled For November 17, 2022
Companies Reporting Before The Bell
• Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million.
Preview: Evogene’s Earnings
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-11-17. Here’s what investors need…
Canonic Launches Its High THC Medical Cannabis Products In Israel
Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN), is launching its second-generation products in Israel.
Aegis Capital Maintains Buy on Evogene, Lowers Price Target to $8
Aegis Capital analyst Nathan Weinstein maintains Evogene (NASDAQ:EVGN) with a Buy and lowers the price target from $10 to $8.